As the Digital Health sector matures, companies are looking to consolidate through partnership and integration, while focusing on building stronger relationships between patients and providers, offering easier access to care, and delivering a more personalized healthcare experience. Strong VC funding in emerging companies has created a fertile environment for new and disruptive technologies for buyers.
After a strong 2021 for M&A in the healthcare sector, 2022 has seen a dramatic downturn in deal activity as the economy slowed, inflation and interest rates rose, global supply chain issues continued, and the Russia-Ukraine war began. With the slowdown, the year’s biggest healthcare deals have focused on acquiring digital capabilities, such as digital care and cloud-based platforms, and Digital Health deal makers are likely to continue to focus on revenue and operational synergies.
Will we continue to see more consolidations that have dominated the market recently? Will more conglomerates enter the market to unlock value? How will rising interest rates, inflation, supply chain concerns, and geopolitical issues impact valuations? In a post-Covid remote world, how are dealmakers adjusting to performing due diligence and post-transaction integration? How is intellectual property and the use of data playing into the Digital Health M&A landscape?
Join us on October 13th at 1:00pm Eastern as The Deal along with global law firm Pillsbury Winthrop Shaw Pittman LLP hosts a roundtable of leading Digital Health M&A dealmakers exploring the digital transformation of the industry.
Ron, the leader of Pillsbury’s Emerging Companies team in New York, maintains a broad-based corporate practice that encompasses securities offerings and compliance, venture capital, mergers and acquisitions, and general corporate law. He also focuses on emerging private and public companies and the technology, biotechnology and telecommunications industries.
Please fill out the form to watch the video replay of the webcast on demand.